Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sandoz Aims For $6bn Biosimilar Business By 2030
Sandoz Has A 22% Share Of Global Biosimilars Market At Present
27 Nov 2020
•
By
Dean Rudge
Sandoz has ambitions to treble the size of its biosimilar business by 2030 • Source: Shutterstock
More from Biosimilars
More from Products